EP2543367 - Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.11.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 29.11.2013 | Application deemed to be withdrawn | published on 01.01.2014 [2014/01] | Applicant(s) | For all designated states Paloma Pharmaceuticals, Inc. 37 Neillian Crescent Jamaica Plain, MA 02130 / US | [2013/02] | Inventor(s) | 01 /
Sherris, David, I. c/o Paloma Pharmaceuticals, Inc. 37 Neillian Crescent Jamaica Plain, MA Massachusetts 02130 / US | [2013/02] | Representative(s) | Duffy, Assumpta Dympna FRKelly 27 Clyde Road Dublin D04 F838 / IE | [N/P] |
Former [2013/02] | Duffy, Assumpta Dympna FRKelly 27 Clyde Road Ballsbridge Dublin 4 / IE | Application number, filing date | 12171847.2 | 28.02.2007 | [2013/02] | Priority number, date | US20060777318P | 28.02.2006 Original published format: US 777318 P | US20060412618 | 27.04.2006 Original published format: US 412618 | [2013/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2543367 | Date: | 09.01.2013 | Language: | EN | [2013/02] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.12.2012 | Classification | IPC: | A61K31/00, A61K31/37 | [2013/02] | CPC: |
A61K31/353 (EP,US);
A61K31/19 (EP,US);
A61K31/352 (EP,US);
A61K31/366 (EP,US);
A61K31/37 (EP,US);
A61K31/382 (EP,US);
A61K31/473 (EP,US);
A61K31/517 (EP,US);
A61K8/37 (EP,US);
A61K8/4926 (EP,US);
A61K8/4953 (EP,US);
A61K8/498 (EP,US);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P17/16 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
A61P39/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2013/02] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | Zusammensetzungen und Verfahren zur Behandlung von durch zelluläre Proliferation und Angiogenese vermittelten Leiden | [2013/02] | English: | Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis | [2013/02] | French: | Compositions et méthodes de traitement de maladies caractérisées par la prolifération cellulaire et l'angiogenèse | [2013/02] | Examination procedure | 10.07.2013 | Application deemed to be withdrawn, date of legal effect [2014/01] | 16.08.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2014/01] | Parent application(s) Tooltip | EP07757634.6 / EP1996021 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070757634) is 14.06.2010 | Fees paid | Renewal fee | 15.10.2012 | Renewal fee patent year 03 | 15.10.2012 | Renewal fee patent year 04 | 15.10.2012 | Renewal fee patent year 05 | 15.10.2012 | Renewal fee patent year 06 | 28.02.2013 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]US2002115711 (SCHMIDT JOHNATHAN MARTIN [CA], et al) [I] 1,3-9 * §0001; §0007; §0010; claim 1, claim 4; example 3; §0039; §0046; Fig. 2-4 * [Y] 1,3-9; | [IY]US2004162281 (BABU YARLAGADDA S [US], et al) [I] 1,3-9 * p. 94, compounds 54, 55; claims 16-20 * [Y] 1,3-9 | [IY] - SCHMIDT J M ET AL, "Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 46, no. 8, doi:10.1021/JM034007D, ISSN 0022-2623, (20030410), pages 1289 - 1292, (20030315), XP002563534 [I] 1,3-9 * compounds 9a, 10; scheme 2; last § of p. 1289 to second § of p. 1290; penultimate § of section "conclusion" on p. 1291 * [Y] 1,3-9 DOI: http://dx.doi.org/10.1021/jm034007d |